Medical Oncology Grand Rounds begin each year after completion of the Friday Introduction to Cancer Management lectures. Fellows and faculty members give 30- to 60-minute, case-based discussions and literature reviews on subjects of their choosing.


  • Friday, Noon-1:00 PM
  • 11th Floor Mid Campus Center, Main Conference Room (in person)
  • Zoom (virtual)

Note: Beginning in July, 2016, Hematology Grand Rounds and Medical Oncology Grand Rounds have been held separately.

Academic year

Jul 7, 2023Michael KramerNucleophosmin Mutations in AML: From the Cell to the Patient
Sep 8, 2023Nathan SinghDetangling CAR-driven T-cell dysfunction
Sep 15, 2023Joshua MitchellTreating the Cancer While Safeguarding the Heart: Seeking Balance from Prevention through Survivorship
Sep 22, 2023Amanda CashenHuman Subjects Research in Oncology: Lessons from a Former IRB Executive Chair
Sep 29, 2023Neha Mehta-ShahTaking Steps Towards Progress in Peripheral T-cell Lymphoma
Oct 6, 2023Piro LitoEmerging KRAS Directed Therapeutics: Implications for Cancer Biology and Therapy
Oct 13, 2023Max WattenbergProgramming the Myeloid Response for Cancer Immunotherapy
Oct 20, 2023Michael SladeThe Goldilocks Principle: Moving Toward Personalized Maintenance in Multiple Myeloma
Oct 27, 2023Ron GermainUsing Advanced Multiplex Microscopy and Computational Tools to Analyze Immune Responses in Normal and Malignant Tissues
Nov 17, 2023Chris CounterRAS mutation tropism -why specific RAS mutations track with specific cancers
Dec 1, 2023Bob MakiEwing Sarcoma: 100+ years of clinical and scientific progress
Dec 15, 2023Brian Van TineTranslating Arginine Deprivation with PEGylated Arginine Deiminase (ADI-PEG 20) in Sarcoma and Other Cancers
Jan 5, 2024Nathan SinghDetangling CAR-driven T-cell dysfunction
Jan 12, 2024CANCELED
Jan 19, 2024Imran NizamuddinMoving the Goalpost in Post-Transplant Lymphoproliferative Disorders: Current Treatments and Future Directions
Jan 26, 2024Funda Meric-Bernstam
Feb 2, 2024Ramon Jin
Feb 9, 2024Greg LongmoreTumour-Environmental Interactions Regulating Cancer Progression
Feb 16, 2024Emily PodanyBiomarker-Directed Neoadjuvant Treatment Decisions in HR+/HER2- Breast Cancer and Impacts on Equity
Feb 23, 2024Russel PachynskiImproving Cellular Therapy and Diagnosis for Metastatic Prostate Cancer Patients
Mar 1, 2024Giulia PetroneThe Landscape of Clonal Hematopoiesis in the Era of Precision Medicine
Mar 8, 2024Patricia LoRussoOptimal Dose Determination in Phase I Clinical Trials
Mar 15, 2024Wilbur SongPearls & Pitfalls of Targeting Tumor Antigens
Mar 22, 2024Constantine LogothetisInflammation in MDS and VEXAS Syndrome: Does One Size Fit All
Mar 29, 2024Brendan KnappImproving Survival in Unresectable Stage II Non-Small Cell Lung Cancer: Moving Beyond PACIFIC
Apr 5, 2024Michael IglesiaCancer Multiomics: Applications and Updates
Apr 12, 2024Margaret ShipGenetic Heterogeneity and Rational Treatment Targets in Lymphoid Malignancies
Apr 19, 2024Miriam Kim
Apr 26, 2024Nicole Foley
May 3, 2024Jesse Zaretsky
May 10, 2024Tanner Johanns
May 17, 2024Michael Kramer
May 24, 2024Nikolaos Trikalinos
May 31, 2024Gio Cittolin Santos
Jun 14, 2024Doug Adkins
Jun 21, 2024Michael Bern
Jun 28, 2024Christine Auberle
Sep 16, 2022Andrew ChowMobilizing the Full Immunological Armamentarium in Lung Cancer
Sep 23, 2022Jeffrey AldrichHighlights From Research in Supportive Care and Outcome Disparities in Breast Cancer
Oct 14, 2022
EPNEC Seminar Room A
Trever Bivona, MD, PhD
University of California San Francisco
Emerging Insights Into Oncogenic RTK-RAS Signaling
Oct 28, 2022Stefan TarnawskyUpdate to the Prognostication and Classification of Myelodysplastic Syndromes
Nov 4, 2022Mohammad Atiq, MD
National Institutes of Health
Exploring Immunocytokine Synergy With Chemotherapy in Metastatic Prostate Cancer
Nov 11, 2022Katherine WeilbaecherBreast Cancer Metastasis in Bone: Insights Into Old Therapies and New Approaches
Dec 16, 2022Maria B. Magella Doyle, MD
Department of Surgery
Transplant Oncology – Making New Strides in Cancer Care
Jan 6, 2023Brad KahlMantle Cell Lymphoma – What Did We Learn in 2022?
Jan 13, 2023Arvind Ravi, MD, PhD
Dana-Farber Cancer Institute
Integrative Approaches to Understanding Therapeutic Response and Resistance
Jan 20, 2023Thomas Westbrook, MD
University of Michigan
Lineage Plasticity in Prostate Cancer: Mechanistic Insight and Therapeutic Implications
Jan 27, 2023David Russler-GermainFollicular Lymphoma: New Insights, Treatments, and Opportunities
Feb 3, 2023Kelly BoltonGermline Genetic Predisposition to Cancer: Paradigm Shifts and Practical Application in Oncology Care
Feb 10, 2023Raya SabaManagement of Diffuse Large B-Cell Lymphoma in Older Patients
Feb 17, 2023Ron BoseTrastuzumab Deruxtecan in Breast, Lung, and Gastroesophageal Cancers
Feb 24, 2023Fahrettin CovutCAR T-Cell and Bispecific Therapies for Relapsed Refractory Multiple Myeloma
Mar 3, 2023Kian-Huat LimTargeting Tumor Innate Inflammation in GI Cancers
Mar 10, 2023Christopher MaherAltered Noncoding Regulation Across Solid Tumors
Mar 17, 2023Priyanka VermaTargeting Base Damage Repair to Overcome Limitations of PARP Inhibitor Thaerapy in BRCA-Mutant Cancers
Mar 24, 2023
Holden Auditorium
Norman “Ned” Sharpless, MD
University of North Carolina
Ending Cancer as We Know It: Forecasting Future Cancer Progress
Mar 31, 2023Akash Patnaik, MD, PhD, MMSc
University of Chicago
Activating Innate Immunity in Prostate Cancer: From Bedside to Bench and Back
Apr 7, 2023Bindiya PatelTargeting MET in NSCLC
Apr 14, 2023Andrew YoungUnderstanding Cancer Risk in Firefighters
Apr 21, 2023Jonathan Trujillo, MD, PhD
University of Chicago
The Role of Cancer Cell-Intrinsic Hypoxia Inducible Factor (HIF) Activation in Tumor Immune Evasion
Apr 28, 2023Danielle Atibalentja, MD, PhD
Stanford University
Deciphering B-Cell Responses in a Pre-Clinical Model of MYC-Driven T-Cell Lymphoma
May 5, 2023Chongj-Xian Pan, MD, PhD
Brigham and Women’s Hospital, Harvard Medical School
Translational Research to Address Unmet Needs in Bladder Cancer
May 12, 2023Jill Phallen, PhD
Johns Hopkins School of Medicine
Liquid Biopsy Approaches and Cell-Free DNA Biology for Early Detection of Cancer
May 19, 2023Matthew ChristopherImproving the Graft-Versus-AML Effect
May 26, 2023Jared CohenAdvances in the Diagnosis and Treatment of Lymphatic Dysgenesis and the Emerging Role of the Medical Oncologist
Jun 9, 2023Andrea Hagemann, MD
Department of Obstetrics & Gynecology
Prioritizing Gynecologic Cancer Prevention: Panel Testing, Preventive Surgeries, and More
Jun 16, 2023Nicole FoleyPersonalizing Therapy for Patients With T-Cell Lymphomas
Jun 23, 2023Giordano Cittolin-SantosSmall Cell Lung Cancer: Changes in Epidemiology and Recent Advances
Jun 30, 2023Michael Iglesia

Jesse Zaretsky
Liver Metastasis: Seed and Soil

Checkpoint Immunotherapy, Beyond Anti-PD1 and CTLA4
Sep 24, 2021Whitney HensingTargeting HER2 in Breast Cancer: New Drugs and Paradigms
Oct 8, 2021Rigoberto Pizarro

Fahrettin Covut
Overview of Health Disparities in Cancer

Minimal Residual Disease in Multiple Myeloma
Oct 15, 2021Raya Saba

Andrew Young
Updates in Frontline Treatment of Chronic Lymphocytic Leukemia

Liquid Biopsy for Cancer Screening
Oct 22, 2021Eric SchwartzFinancial Burdens Surrounding Oral Cancer Therapy
Oct 29, 2021Patricia Ribeiro PereiraNon-Invasive Nuclear Imaging of Cancer Biology to Convert Non-Responders Into Responders
Nov 5, 2021Melissa ReimersUpdates and Recent Advances in Renal Cell Carcinoma
Nov 12, 2021Daniel LinkClonal Hematopoiesis: Etiology and Evolution
Nov 19, 2021Armin GhobadiCellular Therapies for Cancer – A Primer and an Update
Nov 26, 2021Canceled – Holiday
Dec 3, 2021Canceled – ASH Meeting
Dec 10, 2021Canceled – ASH Meeting
Dec 17, 2021Canceled
Dec 24, 2021Canceled – Holiday
Dec 31, 2021Canceled – Holiday
Jan 7, 2022Patrick WhiteInnovative Tools and Strategies for Enhancing Support for Your Oncology Patients and Caregivers
Jan 14, 2022Canceled
Jan 21, 2022Matthew WalterClonal Evolution of Myelodysplastic Syndromes
Jan 28, 2022Srivatsan RaghavanThe Tumor Microenvironment Drives Cell State, Plasticity, and Drug Response in Pancreatic Cancer
Feb 4, 2022Sheila StewartAge-Related Stromal Changes Drive Tumor Progression
Feb 11, 2022Giordano Cittolin-Santos

Jared Cohen
Neoadjuvant Immunotherapy in NSCLC

The Changing Landscape of Treatment in DLBCL
Feb 18, 2022Ravi VijMultiple Myeloma: The Best Is Yet to Come!
Feb 25, 2022Joshua RubinAdapting Cancer Treatment to Sex Differences in Cancer Biology
Mar 4, 2022Jason WeberIdentification of Drivers and Vulnerabilities in Breast Cancer
Mar 11, 2022Jing WuTranslational Research in Developing a CDK9 Inhibitor Towards a Glioma Treatment
Mar 18, 2022Canceled
Mar 25, 2022Bindiya Patel

Michael Kramer
Biomarkers to Guide Adjuvant Therapy in Early-Stage NSCLC

The Proteomic and Phosphoproteomic Landscapes of Acute Myeloid Leukemia
Apr 1, 2022Joseph Franses
Massachusetts General Hospital
Identifying and Targeting Metastatic and Microenvironmental Drivers in Hepatocellular Carcinoma
Apr 8, 2022Todd FehnigerActivate and Recollect: Training Natural Killer Cells for Cancer Immunotherapy
Apr 15, 2022Jing XiA Silent Epidemic? – Disparities in Breast Cancer for Sexual and Gender Minority Women
Apr 22, 2022Miriam JacobsApplications of Memory-Like Natural Killer Cells for Head and Neck Cancer Immunotherapy
Apr 29, 2022Michael Gillette
Broad Institute, Cambridge, MA
Deep Integrated Proteogenomics Reveals New Biology and Therapeutic Vulnerabilities in Non-Small Cell Lung Cancer
May 6, 2022Foluso Ademuyiwa and Mark FialaRacial Disparities in Oncology: Challenges and Opportunities
May 13, 2022Michael IglesiaMetastasis in Colorectal Cancer
May 20, 2022Milan ChhedaTuning In: A Review of Psychedelics for Patients With Cancer
May 27, 2022Nicole Foley

Michael Slade
T-Cell Lymphomas and HSCT

Why CARs Crash: CAR T Cell Treatment Failure and the PD-1/PD-L1 Axis
Jun 3, 2022Canceled – ASCO Meeting
Jun 10, 2022Timothy LeyAML Proteomics and Interactomics
Jun 17, 2022Omar ButtThe Intersection of the Blood Brain Barrier, Neuro-Inflammation, and Neuro-Degeneration in Neuro-Oncology
Jun 24, 2022Charles Swanton
Francis Crick Institute, London, UK
Lung Cancer Evolution, Metastases and Immune Evasion: Insights From TRACERx
Sep 18, 2020Grant ChallenThe Epigenetic Regulation of Hematopoietic Stem Cells: From Clonal Hematopoiesis to Myeloid Neoplasia
Sep 25, 2020Malachi GriffithImmunogenomics Approaches to Identify and Characterize Neoantigens
Oct 9, 2020Andrew YoungClonal Hematopoiesis of Indeterminate and Determinate Potential
Oct 16, 2020Vanessa EuloAdvancing Therapies in Sarcoma
Oct 30, 2020Stephanie Perkins
Radiation Oncology

Brian Baumann
Radiation Oncology
The Role of Proton Therapy in Adult Cancers

The Promise of Proton Therapy as Part of Concurrent Chemo-Radiotherapy
Nov 6, 2020Sid DevarakondaImplications of Cancer-“omics” Studies for Clinical Practice
Nov 13, 2020Ryan Fields
Department of Surgery
The Clonal Evolution of Metastatic Colon Cancer: Insights and Implications for Patient Care
Dec 11, 2020Ian Hu, MD, PhD
National Cancer Institute
Translational Research at NCI
Dec 18, 2020Michael Slade

Michael Iglesia
Assessing Allogeneic Transplant Eligibility in Older Adults

Breast Cancer Subtypes at the Single-Cell Level: Results From the Human Tumor Atlas Network
Jan 8, 2021Sanjeev Bhalla
Department of Radiology
Chest Imaging for the Oncologist
Jan 15, 2021Fahrettin Covut

David Russler-Germain
Advances in Multiple Myeloma Treatment

Integrating Genomics Into Lymphoma Treatment Strategies
Jan 22, 2021Michael Deininger, MD, PhD
Huntsman Cancer Institute, University of Utah
A Critical Role for SIRT5 in Acute Myeloid Leukemia Metabolism
Jan 29, 2021Brian Miller, MD, PhD
Harvard Medical School, Dana Farber Cancer Institute
Defining Immune Mechanisms to Overcome Resistance to Immunotherapy
Feb 5, 2021Amir Iravani
Department of Radiology
Molecular Imaging of Cancer and Immune Response to Immunotherapy
Feb 12, 2021David S. Hong, MD
MD Anderson Cancer Center
Cracking Open the Undruggable RAS
Feb 19, 2021Steven P. Treon, MD, PhD
Dana-Farber Cancer Institute
Treatment Advances in Waldenstrom’s Macroglobulinemia
Feb 26, 2021Whitney Hensing

Raya Saba
Targeting HER2 Mutations in Cancer

Overview and Advances in Treatment of Mantle Cell Lymphoma
Mar 5, 2021Priyanka Verma, PhD
University of Pennsylvania
Chromatin Accessibility: A New Vulnerability in BRCA-Mutant Cancers
Mar 12, 2021Dhruv BansalDiscovering an Immunologic Beachhead in the Prostate Tumor Microenvironment
Mar 19, 2021Elizabeth M. Jaffee, MD
Johns Hopkins University
Pancreatic Cancer Is PRIMED to Become an Immunologic Disease
Mar 26, 2021Barbara Burtness, MD
Yale School of Medicine
The Emerging Therapeutic Landscape in Head and Neck Cancer
Apr 2, 2021Lindsay PetersonPrecision Nutrition in Cancer Care
Apr 9, 2021Zahra Kabiri, MD, PhD
Duke University
Interrogating the Role of Ras and Wnt Signaling Intensity in Colorectal Cancer
Apr 16, 2021Robert Orlowski, MD, PhD
MD Anderson Cancer Center
Novel Antibody Drug Conjugates for Hematologic Malignancies
Apr 23, 2021Miriam JacobsThe Role of Natural Killer Cells in Solid Tumor Immunotherapy
Apr 30, 2021Ramon JinThe Role of SOX2 in Barrett’s Esophagus and Esophageal Adenocarcinoma
May 7, 2021Gradon NielsenImpact of COVID on the Quality of Cancer Care Delivery
May 14, 2021Jing XiThe Emerging Therapeutic Landscape in Breast Cancer With Brain Metastases
May 21, 2021Christian Grommes, MD
Memorial Sloan Kettering Cancer Center
Primary CNS Lymphoma: Current Concepts and Changing Therapeutic Perspectives
May 28, 2021Zachary Crees

Alice Zhou
The GENESIS Trial – CXCR4 Inhibition With Motaxafortide + G-CSF for Hematopoietic Stem Cell Mobilization in Multiple Myeloma

Multiple Myeloma and the Tumor Microenvironment: Focus on NK Cells and Therapeutic Exploitation
Jun 11, 2021Carmen Bergom, MD, PhD
Radiation Oncology
Un-Break My Heart: Using Pre-Clinical and Clinical Data to Minimize Radiation-Induced Heart Dysfunction
Jun 18, 2021Michael KramerMachine Learning for the Oncologist: How the Machines Can Help You Help Patients
Jun 25, 2021Kelsey S. Lau-Min, MD
University of Pennsylvania
Bridging the Evidence-To-Practice Gap in Cancer Care: The Precision Oncology Experience
Jul 2, 2021Ryan DayCore-Binding Factor Leukemias: Mechanism and Treatment
Aug 9, 2019Mark E. Burkard, MD, PhD
University of Wisconsin School of Medicine & Public Health, Madison, WI
Enhancing Precision of Breast Cancer Treatment
Aug 16, 2019Trudy G. Oliver, PhD
University of Utah, Salt Lake City, UT
MYC Drives a Unique Metabolic and Therapeutically-Relevant Subset of Small Cell Lung Cancer
Sep 13, 2019Patrick GriersonThe MK2/Hsp27 Axis as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma
Sep 20, 2019Julien Sage, PhD
Stanford University, Stanford, CA
Mechanisms of Small Cell Lung Cancer Metastasis
Sep 27, 2019Ramon JinOrganoids to Study Upper GI Malignancies
Oct 4, 2019Shivani Ahlawat, MD
Johns Hopkins University, Baltimore, MD
Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Tumors – What Is the State of the Art Imaging?
Oct 18, 2019Gradon Nielsen

Alice Zhou
High Value Cancer Care

Immunosuppression and Tumorigenesis: Lessons From Cyclosporine A on Angiogenesis
Oct 25, 2019Keith Stewart, MB, ChB, MBA
Mayo Clinic, Rochester, MN
Multiple Myeloma: Advances in Diagnostics and Care
Nov 1, 2019Sarat Chandarlapaty, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY
Breast Cancer Resistance to Combination Endocrine Therapy: Mechanisms and Therapeutic Implications
Nov 22, 2019Mary-Kate Malecek

Zachary Crees
Targeting the PI3K Pathway in Cancer

Bone Marrow Niche – Hematopoietic Stem Cell (HSC) Signaling and Therapeutic Implications for Peripheral Blood (PB) HSC Mobilization
Dec 13, 2019John L. Hays, MD, PhD
Ohio State University, Columbus, OH
Finding the Right Targets in Recurrent Ovarian Cancer
Dec 20, 2019Daniel J. Lenihan, MD
Cardiovascular Division
Cardio-Oncology: A New Part of the Team
Jan 10, 2020Ryan Day

Daniel Guy
Maintenance Therapy in AML/MDS

Blastic Plasmacytoid Dendritic Cell Neoplasm
Jan 17, 2020Aadel Chaudhuri
Radiation Oncology
Cell Free DNA Liquid Biopsy: Tumor Surveillance, Risk Stratification and MRD Detection
Jan 24, 2020George SouroullasUnderstanding the Role of EZH2 Mutations on Chromatin Dynamics and Oncogenesis
Jan 31, 2020Brett HerzogModeling Stromal-Induced Immunotherapy Resistance in Lung Cancer
Feb 7, 2020Jason HeldCancer Biochemistry Through the Lens of Chemical and Redox Biology
Feb 14, 2020Francesca FerraroMeasurable Residual Disease (MRD) in AML: Challenges and Opportunities for Intervention
Feb 21, 2020Alessandro VindigniMechanisms of DNA Replication Stress Response to Chemotherapeutics
Feb 28, 2020Mia Weiss, MD
Rush University Medical Center, Chicago, IL
Treatment of Metastatic Soft Tissue Sarcoma in the Era of Next Generation Sequencing
Mar 6, 2020Derek A. Wainwright, PhD
Northwestern University, Chicago, IL
Improving Survival by Reversing the Effects of Aging in Patients With Glioblastoma
Mar 13, 2020Conference suspended until May 1 due to COVID-19
May 1, 2020Lauren Shea

Jing Xi
Treatment of PTLD: Current Approaches and Emerging Therapies

Emerging Novel Therapies for HER2-Positive Metastatic Breast Cancer
May 15, 2020Bruna Pellini FerreiraUrinary Cell-Free DNA Analysis for Tumor Mutation Detection in Patients With Oligometastatic Colorectal Cancer
May 29, 2020Haeseong ParkCOVID-19 and Cancer
Jun 5, 2020Stephen Sykes, PhD
Fox Chase Cancer Center, Philadelphia, PA
The Role and Regulation of Serine Metabolism in Acute Myeloid Leukemia
Jun 12, 2020Michael Iglesia

Miriam Jacobs
Predicting Response to Immunotherapy: PD-L1 and Beyond

The Role of IL-15 as a Cancer Immunotherapy
Jun 19, 2020Whitney Hensing

David Russler-Germain
Immunotherapy in TNBC: Advances in Early Stage Disease

Bispecific Antibodies in Lymphoid Malignancies: Past, Present, and Future
Sep 7, 2018Melissa A. Reimers, MD
University of Michigan, Ann Arbor, MI
Precision Medicine and Immunotherapy in Metastatic Prostate Cancer
Sep 14, 2018Jonathan R. Strosberg, MD
Moffitt Cancer Center, Tampa, FL
Overview of Treatments for Metastatic Gastroenteropancreatic Neuroendocrine Tumors
Sep 28, 2018Matthew J. Ellis, MD, PhD
Baylor College of Medicine, Houston, TX
Breast Cancer Proteogenomics
Oct 5, 2018Benjamin TanLocalized Rectal Cancer: Navigating Shifting Paradigms
Oct 12, 2018Aabha OzaManagement of Advanced Renal Cell Carcinoma
Oct 19, 2018Armin GhobadiCAR-T Cell Therapy and Its Complications
Oct 26, 2018Nabil M. Ahmed, MD, MPH
Baylor College of Medicine, Houston, TX
A Homing System Targets Therapeutic T Cells to Brain Cancer
Nov 2, 2018Kenneth C. Anderson, MD
Dana-Farber Cancer Institute, Boston, MA
Novel Therapeutic Strategies in Multiple Myeloma
Nov 9, 2018Nkiruka Ezenwajiaku

Ramon Jin
Molecular Classification of Triple Negative Breast Cancer

GI Organoids in Cancer Research
Dec 7, 2018Amber XuTarget Therapy in Non-Small Cell Lung Cancer
Dec 14, 2018Milan ChhedaUsing Zika Virus to Target Glioblastoma Stem Cells
Jan 4, 2019Kristen SanfilippoCancer Associated Thrombosis: Prevention to Treatment
Jan 11, 2019Brett Herzog

Ramzi Abboud
Fibrosis Modulates Lung Cancer Immunity and Progression

Invariant NKT Cells: Harnessing Their Immunoregulatory and Effector Functions
Jan 18, 2019David DeNardoTargeting the Pancreas Cancer Tumor Microenvironment to Improve Response to Immunotherapy
Jan 25, 2019Gradon Nielsen

Lauren Shea
Economic Challenges in Modern Oncology and the Need for Innovation

Treatment of Brain Metastases in Non-Small Cell Lung Cancer
Feb 1, 2019Kian LimTargeting the Innate Immune Inflammatory Pathway in Pancreatic Cancer
Feb 8, 2019Bruna Pellini Ferreira

Daniel Guy
Urinary cfDNA in Lung Cancer Surveillance: Present and Future Directions

Bispecific Antibodies for Treatment of AML
Feb 15, 2019Meagan JacobyCan Measurable Residual Disease Monitoring Post-Transplant Improve Outcomes for MDS Patients?
Feb 22, 2019James HsiehClinical and Translational Kidney Cancer Research: Now & Future
Mar 1, 2019Katherine Clifton, MD
MD Anderson Cancer Center, Houston, TX
Exploring Oral Therapy Options in Geriatric Oncology: Analysis of Toxicity and Efficacy Of CDK4/6 Inhibitors in Metastatic Breast Cancer
Mar 15, 2019Sunyoung Lee, MD, PhD
Roswell Park Comprehensive Cancer Center, Buffalo, NY
Immune Profiling and Prognostication of Lung and Pancreatic Adenocarcinoma
Mar 22, 2019Karin Hickey, MD
Division of Endocrinology, Metabolism & Lipid Research
Endocrine Disorders in Cancer Patients
Mar 29, 2019Angela HirbeClinical Challenges in the Diagnosis and Management of Neurofibromatosis-associated MPNSTs
Apr 5, 2019John WelchIntegrating Next-Generation Sequencing Into AML and MDS Clinical Trials
Apr 19, 2019Matthew ChristopherAML and the Graft-Versus-Leukemia Effect
Apr 26, 2019Vanessa Eulo

Scott Goldsmith
Immunotherapy in Advanced Sarcoma

Unfolding the Unfolded Protein Response: Implications for Cancer Therapy
May 3, 2019Charles KaufmanEpigenetic Regulators of Melanoma Initiation
May 10, 2019David SpencerUnderstanding Aberrent DNA Methylation in Leukemia
May 17, 2019Tanner JohannsNeoantigens as Therapeutic Targets in Glioblastoma
May 24, 2019Ryan Day

Mary-Kate Malecek
Targeting Apoptosis in AML

Novel Therapies in Primary CNS Lymphoma
Jun 7, 2019Amber Afzal

Miriam Jacobs
CDK9 Inhibition in Acute Myeloid Leukemia

Use of Cytokine Induced Memory Like NK Cells for Relapsed Refractory AML
Jun 14, 2019Michael Green, MD
MD Anderson Cancer Center, Houston, TX
Epigenetic Targeting of B-Cell Lymphoma
Jun 21, 2019Obi GriffithSurveying the Genomic Landscape of Tumors and Tumor Models – The Next Frontier
Jun 28, 2019Gerald P. Linette, MD, PhD
University of Pennsylvania, Philadelphia, PA
Immunological Ignorance of Solid Tumors
Aug 25, 2017Nusayba BagegniOvercoming Drug Resistance in HER2+ Breast Cancer
Sep 1, 2017Ravi VijMM: AK47 or M24
Sep 15, 2017Natasha EdwinPhysician Immigration and the US
Sep 22, 2017Jeffrey S. Miller, MD
University of Minnesota
Novel Ways to Activate NK Cells to Treat Cancer
Sep 29, 2017Emily Jungheim, MD, MSCI
Obstetrics and Gynecology
Fertility Preservation in 2017 at Washington University
Oct 6, 2017Brad KahlMantle Cell Lymphoma: The State of the State
Oct 13, 2017Craig H. Moskowitz, MD
Memorial Sloan Kettering Cancer Center
Hodgkin Lymphoma in the Near Future: Impact of Modern Nuclear Medicine, Radiotherapy, Brentuximab Vedotin and the Checkpoint Inhibitors
Oct 20, 2017Miriam Jacobs

Ramon Jin
Immunotherapy in Metastatic Squamous Cell Head and Neck Cancer

Cancer Stem Cells in Solid Tumors
Oct 27, 2017Bita FakhriCurrent and Emerging Treatment Strategies for Relapsed and Refractory Multiple Myeloma
Nov 3, 2017Ron BoseHer2 Activating Mutations and the Challenge of Variants of Unknown Significance (VUS) in Breast Cancer Patients
Nov 10, 2017Daniel J. Lenihan, MD
Cardiovascular Division
Cardio Oncology: How Can We Improve Practice?
Nov 17, 2017Eric HuseltonImproving Outcomes After Allogeneic Tranplant: Risk Factors and Treatment of Relapsed AML
Dec 1, 2017Ramzi Abboud

Brett Herzog
JAK/STAT Pathways and Immunomodulation After Hematopoietic Cell Transplantation and Other Immune Therapies

Clonal Dynamics of Non-Small Cell Lung Cancer
Dec 15, 2017Doug AdkinsCurrent Clinical Investigations in Head and Neck Cancer at Washington University
Dec 22, 2017Vivek AroraEmerging Concepts in Bladder Cancer Management
Jan 5, 2018Brian Van TineSarcoma Metabolism
Jan 12, 2018Neha Mehta-ShahT-Cell Lymphomas: Where We Are and Where We Hope to Be
Jan 19, 2018Brigitte C. Widemann, MD
Pediatric Oncology Branch, NCI
Development of Effective Therapies for NF1 Related Peripheral Nerve Sheath Tumors
Jan 26, 2018Daniel Guy

Amber Xu
Age-Related Clonal Hematopoiesis

Past, Present and Future of PARP Inhibition
Feb 2, 2018Lawrence Einhorn, MD
Indiana University
Testicular Cancer: Past History, Present Results and Future Perspectives
Feb 9, 2018Bruna Pellini Ferreira

Nkiruka Ezenwajiaku
Cell Tumor DNA in the Diagnosis and Follow-Up of NSCLC

Mixed Phenotype Acute Leukemia
Feb 16, 2018John P. Leonard, MD
Weill Cornell Medical College
New Developments in Lymphoma: Progress and Problems in Precision Therapy
Feb 23, 2018David T. Curiel, MD, PhD
Radiation Oncology
Molecular Engineering of Adenovirus to Actualize Cancer Vaccines
Mar 2, 2018Thomas M. Maddox, MD, MSc
Cardiovascular Division
The Health Systems Innovation Lab: Opportunities to Think Differently About Cancer Care
Mar 9, 2018Monte Meier Winslow, PhD
Stanford University
Molecular Determinants of Lung Cancer Growth and Metastasis
Mar 16, 2018Daniel Guy

Aabha Oza
Prevention of CMV Infection in Patients Undergoing HSCT

Progressive Multifocal Leukoencephaolpathy
Mar 30, 2018Russell W. Jenkins, MD, PhD
Dana-Farber/Harvard Cancer Center
Ex-Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids: Developing a Functional Precision Medicine Platform for Immuno-Oncology
Apr 6, 2018Ramon Jin

Patrick Grierson
Metaplasia: The Calm Before the Storm?

Targeting the MAPK Pathway in Solid Tumors
Apr 13, 2018Lee RatnerPathogenesis and Treatment of Human T-Cell Leukemia Virus Associated Malignancy
Apr 20, 2018John DiPersioTherapeutic Targeting of Hematologic Malignancies
Apr 27, 2018Jeff WardRemodeling of Intratumoral Myeloid and Lymphoid Compartments Following Immune Checkpoint Blockade Therapy
May 18, 2018Jeffrey A. Moscow, MD
Cancer Therapy Evaluation Program, NCI
Precision Cancer Medicine and the NCI’s Experimental Therapeutics Clinical Trials Network (ETCTN)
May 25, 2018Russell PachynskiChemerin in Cancer
Jun 8, 2018Matthew A. Ciorba, MD
Gastroenterology Division
Save IDO Inhibitors! A Role for Tryptophan Metabolism in Colon Cancer
Jun 15, 2018Francesca Ferraro

Amber Afzal
From MGUS to MGCS: When the “Uncertain” Turns to “Ugly”

BCL2 Inhibition in Myeloid Malignancies
Jun 22, 2018Gad Getz, PhD
Harvard Medical School
Studying Response and Resistance to Therapy in Cancer
Jun 29, 2018Pasi A. Jänne, MD, PhD
Harvard Medical School
New Therapeutic Stratgies for EGFR Mutant Lung Cancer
Writing Chemo Orders: The Basics I Must Know and Implement
Jul 2, 2016Janelle Mann
Staff Pharmacist, Medical Oncology
The Ins and Outs of Anti-Emetics
Metastatic Hormone Positive Breast Cancer
Non-Small Cell Lung Cancer
Head and Neck Cancer
Aug 19, 2016William D. Tap, MD
Memorial Sloan Kettering Cancer Center, New York, NY
The Pit and the Pendulum, Emerging Therapies in Soft Tissue Sarcoma
Hodgkin Lymphoma
Sep 2, 2016Nancy BartlettTargeted Approaches to Diffuse Large B Cell Lymphoma
Sep 9, 2016Timothy LeyAcute Myeloid Leukemia
Sep 16, 2016Todd FehnigerNatural Killer Cell Immunotherapy: Prime or Recollect?
Sep 23, 2016Gloria M. Petersen, PhD
Mayo Clinic College of Medicine, Rochester, MN
Genetic Susceptibility to Pancreatic Cancer: New Insights
Sep 30, 2016Todd Druley
Pediatric Hematology/Oncology
Leukemia-associated Clonal Hematopoiesis Is a Ubiquitous Process in Normal Aging
Oct 7, 2016Cynthia MaCDK 4/6 in ER+ Breast Cancer
Oct 14, 2016Lingling Du
Hematology-Oncology Fellow
IDO Inhibition in Cancer Treatment
Oct 21, 2016Gideon M. Blumenthal, MD
Center for Drug Evaluation and Research, FDA, Bethesda, MD
Clinical Trials and Drug Development in Oncology: FDA’s Perspective
Oct 28, 2016Katherine WeilbaecherTargeting Dormant and Growing Bone Metastases
Nov 4, 2016Craig LockhartStrategic Targeting of Esophageal Cancers: 2016 Update
Nov 11, 2016Bita Fakhri
Hematology-Oncology Fellow

Amber Xu
Hematology-Oncology Fellow
Livin’ on a Prayer: Double and Triple Hit Lymphomas

Paraneoplastic Opsoclonus-Myoclonus Syndrome
Nov 18, 2016Sana Saif Ur Rehman
Hematology-Oncology Fellow
Chronic Neutrophilic Leukemia: Novel Mutations and Impact on Clinical Practice
Dec 9, 2016Tom Regenbogen
Hematology-Oncology Fellow
Non-Surgical Liver Directed Therapy
Dec 16, 2016Mark Watson
Laboratory & Genomic Medicine
Detection of Rare Tumor Cells
Jan 6, 2017Scott Kopetz, MD, PhD
MD Anderson Cancer Center, Houston, TX
Targeting BRAF in Colorectal Cancer
Jan 20, 2017Francesca Ferraro
Hematology-Oncology Fellow

Eric Huselton
Hematology-Oncology Fellow
Hypomethylating Agents in Acute Myeloid Leukemia

BCL-2 Inhibition in CLL
Jan 27, 2017Marcel van den Brink, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY
Strategies to Enhance Hematopoietic Stem Cell Transplantation
Feb 3, 2017Sid Devarakonda
Hematology-Oncology Fellow
Origins and Genomic Landscape of Small Cell Lung Cance
Feb 10, 2017Sam Achilefu
Light Mediated Molecular Imaging and Treatment of Cancer
Feb 17, 2017Maria-Grazia Roncarolo, MD
Stanford University, Stanford, CA
T Regulatory Cells in Immunomediated Diseases: From Bench to Bedside and Beyond
Feb 24, 2017Richard Wahl
Quantitative Imaging to Phenotype Patients With Cancer
Mar 3, 2017Deborah Schrag, MD, MPH
Dana-Farber Cancer Institute, Boston, MA
Pilots to Populations: Quality, Efficacy and Effectiveness of Rectal Cancer Treatment
Mar 10, 2017Andy Liao
Hematology-Oncology Fellow
Emerging Treatment Options in Cholangiocarcinoma
Mar 17, 2017Amanda CashenCAR T-Cells: How Will We Weigh the Risks and Benefits?
Mar 24, 2017Ezra Cohen, MD
UC San Diego, La Jolla, CA
Immune Approaches in Head and Neck Cancer
Mar 31, 2017Natasha Edwin
Hematology-Oncology Fellow

Patrick Grierson
Hematology-Oncology Fellow
Burnout Among Oncologists

Immunotherapy in GI Malignancies
Apr 7, 2017Aabha Oza
Hematology-Oncology Fellow

Stephen Barman
Hematology-Oncology Fellow
Peritoneal Carcinomatosis: Intraperitoneal Chemotherapy and Cytoreductive Surgery

Urothelial Carcinoma: Review and Updates of Second-Line Treatment
Apr 14, 2017Goutham Narla, MD, PhD
Case Western Reserve University, Cleveland, OH
Novel Therapies to Activate Tumor Suppressor Proteins for Cancer Treatment
Apr 21, 2017Kwok-Kin Wong, MD, PhD
NYU Langone Medical Center, New York, NY
The Use of Mouse Lung Cancer Models for Preclinical Testing of Novel Targeted and Immune Therapies
Apr 28, 2017Vassiliki Saloura, MD
University of Chicago
WHSC1L1 as an Oncogenic Methyltransferase in Head and Neck Cancer: Progress Towards Clinical Translation
May 5, 2017Tanya WildesAge Is Just a Surrogate for Aging: Weaving the Principals of Geriatrics Into the Fabric of Oncology
May 12, 2017Tanner Johanns
Hematology-Oncology Fellow
hTERT as an Immunologic Target
May 19, 2017Nusayba Bagegni
Hematology-Oncology Fellow

Francesca Ferraro
Hematology-Oncology Fellow
Management of Leptomeningeal Disease

Secondary ALL (Acute Lymphoblastic Leukemia): A Real Entity?
May 26, 2017Nkiruka Ezenwajiaku
Hematology-Oncology Fellow

Amber Afzal
Hematology-Oncology Fellow
Hepatic Veno-Occlusive Disease

Outcomes of Stem Cell Transplant in Myelofibrosis
Jun 9, 2017Patrick Grierson
Hematology-Oncology Fellow

Pavan Bhamidipati
Hematology-Oncology Fellow
NK Cell Lymphoma

IDH Mutations in AML and Novel Therapeutics
Jun 16, 2017Chris MaherThe Biological and Clinical Significance of Long Non-Coding RNAs
Jun 23, 2017Matt WalterGenomics of Myelodysplastic Syndromes
Jun 30, 2017F. Stephen Hodi, MD
Dana-Farber Cancer Institute, Boston, MA
Combinatorial Approaches With Immune Checkpoint Blockade to Treat Cancer